Access Menu

Log in via Social

Log in with LinkedIn
CANNABINOID BIOSCIENCES, INC.
CANNABINOID BIOSCIENCES
Opportunity to get in on the ground floor of CBD investment, with a $10 Reg. A+ T2 Stock set for 2020 NASDAQ IPO. (OTC PINK: KDCE)
Raised$7,765,500 of $5M
155% of goal
$
1st Female-Controlled CBD Fund about to IPO on NASDAQ or NYSE and CSE
View Company